CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
出版年份 2019 全文链接
标题
CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
作者
关键词
-
出版物
Cancer Cell International
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-07
DOI
10.1186/s12935-019-0997-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Consensus guidelines for the use and interpretation of angiogenesis assays
- (2018) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- A prodrug of green tea polyphenol (–)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer
- (2018) Jianzhang Wang et al. CANCER LETTERS
- CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer
- (2018) Chao-Hui Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma
- (2018) Jinduan Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor angiogenesis and bone metastasis - Correlation in invasive breast carcinoma
- (2018) Chong Sun et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
- (2017) Vera Loizzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma
- (2017) Lipin Liu et al. Molecular Cancer
- Neuroendocrine Tumors of the Stomach
- (2017) Britney Corey et al. SURGICAL CLINICS OF NORTH AMERICA
- Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma
- (2017) Jiehui Di et al. TUMOR BIOLOGY
- Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway
- (2017) Daejin Kim et al. Experimental and Therapeutic Medicine
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro
- (2016) J. Jacob Wamsley et al. CELL CYCLE
- Vegfa signals through ERK to promote angiogenesis, but not artery differentiation
- (2016) Masahiro Shin et al. DEVELOPMENT
- Regulation of the Human Ghrelin Promoter Activity by Transcription Factors, NF-κB and Nkx2.2
- (2015) Yuki Shiimura et al. International Journal of Endocrinology
- Gastric neuroendocrine neoplasms and related precursor lesions
- (2014) Stefano La Rosa et al. JOURNAL OF CLINICAL PATHOLOGY
- Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication
- (2014) Yoshinori Hoshino et al. Molecular Cancer
- Cornin induces angiogenesis through PI3K–Akt–eNOS–VEGF signaling pathway
- (2013) Zechun Kang et al. FOOD AND CHEMICAL TOXICOLOGY
- Suppression of VEGF expression through interruption of the HIF-1α and Akt signaling cascade modulates the anti-angiogenic activity of DAPK in ovarian carcinoma cells
- (2013) SUNG TAEK PARK et al. ONCOLOGY REPORTS
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
- (2012) H. Sorbye et al. ANNALS OF ONCOLOGY
- Current Concepts on Gastric Carcinoid Tumors
- (2012) George C. Nikou et al. Gastroenterology Research and Practice
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- TNM-System 2010
- (2010) C. Wittekind PATHOLOGE
- Estrogen Rapidly Activates the PI3K/AKT Pathway and Hypoxia-Inducible Factor 1 and Induces Vascular Endothelial Growth Factor A Expression in Luminal Epithelial Cells of the Rat Uterus1
- (2009) Armina A. Kazi et al. BIOLOGY OF REPRODUCTION
- PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines
- (2009) Norazizah Shafee et al. CANCER LETTERS
- Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation
- (2009) Hai Jiang et al. CELL RESEARCH
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started